Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: implication for prostate cancer risk.

Saved in:
Bibliographic Details
Title: Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: implication for prostate cancer risk.
Authors: Kakinuma, H.1, Tsuchiya, N.1, Habuchi, T.1 thabuchi@doc.med.akita-u.ac.jp, Ohyama, C.1, Matsuura, S.1, Wang, L.1, Nakamura, A.2, Kato, T.1
Source: Prostate Cancer & Prostatic Diseases. 2004, Vol. 7 Issue 4, p333-337. 5p. 4 Charts.
Database: Academic Search Ultimate
Description
ISSN:13657852
DOI:10.1038/sj.pcan.4500753